
Kara E. Geisel
Supervisory Patent Examiner (ID: 3928, Phone: (571)272-2416 , Office: P/2877 )
| Most Active Art Unit | 2877 |
| Art Unit(s) | RD00, 2877 |
| Total Applications | 979 |
| Issued Applications | 748 |
| Pending Applications | 84 |
| Abandoned Applications | 154 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6143430
[patent_doc_number] => 20110129921
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-02
[patent_title] => 'TARGETED POLYMER BIOCONJUGATES'
[patent_app_type] => utility
[patent_app_number] => 12/992545
[patent_app_country] => US
[patent_app_date] => 2009-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 22004
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20110129921.pdf
[firstpage_image] =>[orig_patent_app_number] => 12992545
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/992545 | TARGETED POLYMER BIOCONJUGATES | May 12, 2009 | Abandoned |
Array
(
[id] => 6112751
[patent_doc_number] => 20110190151
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-04
[patent_title] => 'METHODS OF DIAGNOSING CHRONIC CARDIAC ALLOGRAFT REJECTION'
[patent_app_type] => utility
[patent_app_number] => 12/937221
[patent_app_country] => US
[patent_app_date] => 2009-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 22226
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20110190151.pdf
[firstpage_image] =>[orig_patent_app_number] => 12937221
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/937221 | METHODS OF DIAGNOSING CHRONIC CARDIAC ALLOGRAFT REJECTION | Apr 8, 2009 | Abandoned |
Array
(
[id] => 6070151
[patent_doc_number] => 20110045001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-24
[patent_title] => 'Transfection results of non-viral gene delivery systems by influencing of the innate immune system'
[patent_app_type] => utility
[patent_app_number] => 12/412550
[patent_app_country] => US
[patent_app_date] => 2009-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 24296
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20110045001.pdf
[firstpage_image] =>[orig_patent_app_number] => 12412550
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/412550 | Transfection results of non-viral gene delivery systems by influencing of the innate immune system | Mar 26, 2009 | Abandoned |
Array
(
[id] => 6098159
[patent_doc_number] => 20110003892
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-06
[patent_title] => 'ALL-TRANS RETINOID ESTERS AS ACTIVE PHARMACEUTICAL INGREDIENTS, ORAL AND TOPICAL DOSAGE FORM COMPOSITIONS THEREOF, AND METHODS OF TREATING SKIN CONDITIONS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/920540
[patent_app_country] => US
[patent_app_date] => 2009-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7656
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20110003892.pdf
[firstpage_image] =>[orig_patent_app_number] => 12920540
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/920540 | ALL-TRANS RETINOID ESTERS AS ACTIVE PHARMACEUTICAL INGREDIENTS, ORAL AND TOPICAL DOSAGE FORM COMPOSITIONS THEREOF, AND METHODS OF TREATING SKIN CONDITIONS THEREOF | Mar 5, 2009 | Abandoned |
Array
(
[id] => 6136993
[patent_doc_number] => 20110009454
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-13
[patent_title] => 'COMPOSITION FOR AGRICULTURAL USE FOR CONTROLLING OR PREVENTING PLANT DISEASES CAUSED BY PLANT PATHOGENS'
[patent_app_type] => utility
[patent_app_number] => 12/919441
[patent_app_country] => US
[patent_app_date] => 2009-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 140008
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20110009454.pdf
[firstpage_image] =>[orig_patent_app_number] => 12919441
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/919441 | COMPOSITION FOR AGRICULTURAL USE FOR CONTROLLING OR PREVENTING PLANT DISEASES CAUSED BY PLANT PATHOGENS | Feb 26, 2009 | Abandoned |
Array
(
[id] => 9983705
[patent_doc_number] => 09029419
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-05-12
[patent_title] => 'Use of zinc N-acetyltaurinate'
[patent_app_type] => utility
[patent_app_number] => 12/918990
[patent_app_country] => US
[patent_app_date] => 2009-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 9
[patent_no_of_words] => 2912
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12918990
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/918990 | Use of zinc N-acetyltaurinate | Feb 24, 2009 | Issued |
Array
(
[id] => 6212927
[patent_doc_number] => 20110136227
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-09
[patent_title] => 'OPTIMISATION OF EXPRESSION OF PARVOVIRAL REP AND CAP PROTEINS IN INSECT CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/918460
[patent_app_country] => US
[patent_app_date] => 2009-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 17101
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20110136227.pdf
[firstpage_image] =>[orig_patent_app_number] => 12918460
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/918460 | Optimization of expression of parvoviral rep and cap proteins in insect cells | Feb 18, 2009 | Issued |
Array
(
[id] => 6055142
[patent_doc_number] => 20110111502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-12
[patent_title] => 'ELIMINATION OF IMMUNE RESPONSES TO VIRAL VECTORS'
[patent_app_type] => utility
[patent_app_number] => 12/735754
[patent_app_country] => US
[patent_app_date] => 2009-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 13451
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20110111502.pdf
[firstpage_image] =>[orig_patent_app_number] => 12735754
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/735754 | Elimination of immune responses to viral vectors | Feb 15, 2009 | Issued |
Array
(
[id] => 11357391
[patent_doc_number] => 09534035
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-03
[patent_title] => 'Cell lines expressing ENaC and methods using them'
[patent_app_type] => utility
[patent_app_number] => 12/864295
[patent_app_country] => US
[patent_app_date] => 2009-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 17062
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12864295
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/864295 | Cell lines expressing ENaC and methods using them | Jan 24, 2009 | Issued |
Array
(
[id] => 5993061
[patent_doc_number] => 20110014714
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-20
[patent_title] => 'METHOD FOR SELECTIVE LABELING OF PROTEIN PRODUCED BY IN VITRO TRANSLATION BY USING A MARKER FROM TRNA PREPARED BY USING IN VITRO TRANSCRIPTION'
[patent_app_type] => utility
[patent_app_number] => 12/812382
[patent_app_country] => US
[patent_app_date] => 2009-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9303
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20110014714.pdf
[firstpage_image] =>[orig_patent_app_number] => 12812382
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/812382 | Method for selective labeling of protein produced by in vitro translation by using a marker from tRNA prepared by using in vitro transcription | Jan 6, 2009 | Issued |
Array
(
[id] => 5929770
[patent_doc_number] => 20110039729
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-17
[patent_title] => 'GLYCOSYLATED PROTEIN EXPRESSION IN PROKARYOTES'
[patent_app_type] => utility
[patent_app_number] => 12/811788
[patent_app_country] => US
[patent_app_date] => 2009-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 17797
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20110039729.pdf
[firstpage_image] =>[orig_patent_app_number] => 12811788
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/811788 | Glycosylated protein expression in prokaryotes | Jan 4, 2009 | Issued |
Array
(
[id] => 5929762
[patent_doc_number] => 20110039721
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-17
[patent_title] => 'METHOD FOR PREDICTION ABOUT CARCINOGENICITY OF SUBSTANCE IN RODENT'
[patent_app_type] => utility
[patent_app_number] => 12/810100
[patent_app_country] => US
[patent_app_date] => 2008-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11633
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20110039721.pdf
[firstpage_image] =>[orig_patent_app_number] => 12810100
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/810100 | METHOD FOR PREDICTION ABOUT CARCINOGENICITY OF SUBSTANCE IN RODENT | Dec 25, 2008 | Abandoned |
Array
(
[id] => 6071155
[patent_doc_number] => 20110046006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-24
[patent_title] => 'MEANS AND METHODS FOR TYPING A CELL ISOLATE OF AN INDIVIDUAL SUFFERING FROM A PSYCHIATRIC DISORDER OR AT RISK OF SUFFERING THERE FROM'
[patent_app_type] => utility
[patent_app_number] => 12/808642
[patent_app_country] => US
[patent_app_date] => 2008-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 19826
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20110046006.pdf
[firstpage_image] =>[orig_patent_app_number] => 12808642
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/808642 | MEANS AND METHODS FOR TYPING A CELL ISOLATE OF AN INDIVIDUAL SUFFERING FROM A PSYCHIATRIC DISORDER OR AT RISK OF SUFFERING THERE FROM | Dec 18, 2008 | Abandoned |
Array
(
[id] => 6055141
[patent_doc_number] => 20110111501
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-12
[patent_title] => 'COMPLEX OF POLYSACCHARIDE AND DOUBLE-STRANDED RNA'
[patent_app_type] => utility
[patent_app_number] => 12/808504
[patent_app_country] => US
[patent_app_date] => 2008-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 12574
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20110111501.pdf
[firstpage_image] =>[orig_patent_app_number] => 12808504
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/808504 | Complex of polysaccharide and double-stranded RNA | Dec 17, 2008 | Issued |
Array
(
[id] => 7573527
[patent_doc_number] => 20110269183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-03
[patent_title] => 'RECOMBINANT MICROORGANISM HAVING AN ABILITY OF USING SUCROSE AS A CARBON SOURCE'
[patent_app_type] => utility
[patent_app_number] => 12/808533
[patent_app_country] => US
[patent_app_date] => 2008-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 12892
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20110269183.pdf
[firstpage_image] =>[orig_patent_app_number] => 12808533
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/808533 | RECOMBINANT MICROORGANISM HAVING AN ABILITY OF USING SUCROSE AS A CARBON SOURCE | Dec 17, 2008 | Abandoned |
Array
(
[id] => 6070686
[patent_doc_number] => 20110045536
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-24
[patent_title] => 'MAMMALIAN EXPRESSION VECTOR'
[patent_app_type] => utility
[patent_app_number] => 12/808798
[patent_app_country] => US
[patent_app_date] => 2008-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12734
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20110045536.pdf
[firstpage_image] =>[orig_patent_app_number] => 12808798
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/808798 | MAMMALIAN EXPRESSION VECTOR | Dec 17, 2008 | Abandoned |
Array
(
[id] => 11930001
[patent_doc_number] => 09796987
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-24
[patent_title] => 'Polypurine tract modified retroviral vectors'
[patent_app_type] => utility
[patent_app_number] => 12/747076
[patent_app_country] => US
[patent_app_date] => 2008-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7820
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12747076
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/747076 | Polypurine tract modified retroviral vectors | Dec 10, 2008 | Issued |
Array
(
[id] => 6569520
[patent_doc_number] => 20100273263
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-28
[patent_title] => 'CELL CULTURE VESSEL AND METHOD OF PRODUCTION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/747826
[patent_app_country] => US
[patent_app_date] => 2008-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7664
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0273/20100273263.pdf
[firstpage_image] =>[orig_patent_app_number] => 12747826
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/747826 | Cell culture vessel and method of production thereof | Dec 10, 2008 | Issued |
Array
(
[id] => 6400645
[patent_doc_number] => 20100304992
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-02
[patent_title] => 'DIAGNOSIS KIT AND CHIP FOR BLADDER CANCER USING BLADDER CANCER SPECIFIC METHYLATION MARKER GENE'
[patent_app_type] => utility
[patent_app_number] => 12/744491
[patent_app_country] => US
[patent_app_date] => 2008-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10541
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0304/20100304992.pdf
[firstpage_image] =>[orig_patent_app_number] => 12744491
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/744491 | DIAGNOSIS KIT AND CHIP FOR BLADDER CANCER USING BLADDER CANCER SPECIFIC METHYLATION MARKER GENE | Nov 30, 2008 | Abandoned |
Array
(
[id] => 8725371
[patent_doc_number] => 08404486
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-03-26
[patent_title] => 'Recombination sequences'
[patent_app_type] => utility
[patent_app_number] => 12/744754
[patent_app_country] => US
[patent_app_date] => 2008-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 20562
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12744754
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/744754 | Recombination sequences | Nov 27, 2008 | Issued |